The Medical Advisor

Background on Salivary Gland Cancer Salivary gland cancer is a rare malignancy affecting the salivary glands (e.g., parotid, submandibular, or sublingual glands), with subtypes like adenoid cystic carcinoma and mucoepidermoid carcinoma. Standard treatments include surgery, radiation, and sometimes chemotherapy, but outcomes vary depending on stage and subtype, with advanced cases often having limited options. ​ Exploring alternative and adjunctive therapies for stage 4 salivary gland cancer is understandable, especially when conventional treatments have limited efficacy.  There is limited publicly available, peer-reviewed evidence specifically documenting success stories of Fenbendazole, Ivermectin, Mebendazole, Vitamin D3, Curcumin, Berberine and Cimetidine use in treating salivary gland cancer in humans.  Ivermectin and Fenbendazole, traditionally used as antiparasitics (Fenbendazole in veterinary medicine and Ivermectin in humans and animals), have gained attention for thei...

There is limited publicly available, peer-reviewed evidence specifically documenting success stories of Fenbendazole and Ivermectin use in treating salivary gland cancer in humans. Both drugs, traditionally used as antiparasitics (Fenbendazole in veterinary medicine and Ivermectin in humans and animals), have gained attention for their potential anticancer properties based on preclinical studies and anecdotal reports. However, clinical data remains scarce, particularly for rare cancers like salivary gland cancer. Below, we’ll summarize the available context and relevant anecdotal evidence. Background on Salivary Gland Cancer Salivary gland cancer is a rare malignancy affecting the salivary glands (e.g., parotid, submandibular, or sublingual glands), with subtypes like adenoid cystic carcinoma and mucoepidermoid carcinoma. Standard treatments include surgery, radiation, and sometimes chemotherapy, but outcomes vary depending on stage and subtype, with advanced cases often having limite...